Discovery in the nature of pharmaceutical research, development, engineering and testing, namely, for multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

'allergi':48 'autoimmun':40 'bind':17 'biomolecul':27 'cancer':49 'caus':23 'circul':20 'condit':45 'degrad':33 'develop':8 'discoveri':1 'diseas':22,43,51 'disease-caus':21 'disord':41,47,54 'engin':9 'extracellular':19 'infecti':50 'inflammatori':42 'lysosom':32 'metabol':46 'molecul':15 'multifunct':14 'name':12 'natur':4 'neurolog':53 'pharmaceut':6 'protein':24 'research':7 'target':29 'test':11 'treatment':38 'use':35

Pharmaceutical products, namely, multifunctional molecules that bind to extracellular circulating disease-causing proteins and other biomolecules and target them for lysosomal degradation, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

'allergi':38 'autoimmun':30 'bind':7 'biomolecul':17 'cancer':39 'caus':13 'circul':10 'condit':35 'degrad':23 'diseas':12,33,41 'disease-caus':11 'disord':31,37,44 'extracellular':9 'infecti':40 'inflammatori':32 'lysosom':22 'metabol':36 'molecul':5 'multifunct':4 'name':3 'neurolog':43 'pharmaceut':1 'product':2 'protein':14 'target':19 'treatment':28 'use':25

MODE

Owners

Goods & Services